Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal

被引：23
作者：
Silva-Costa, C [1 ]
Ramirez, A [1 ]
Meto-Cristino, J [1 ]
机构：
[1] Inst Mol Med, Microbiol Lab, Mol Microbiol & Infect Unit, Lisbon Fac Med, P-1649028 Lisbon, Portugal
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 05期
关键词：
D O I：
10.1128/AAC.49.5.2109-2111.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In Portugal erythromycin resistance of 26.6% (n = 352) remained constant during 1998 to 2003, however in 1998 the MLSB phenotype dominated (85%), whereas in 2003 the M phenotype prevailed (77%). A decline in T12/emm22 MLSB isolates could partially explain the drop in this phenotype, but the rise of the M phenotype was not due to clonal expansion.
引用
收藏
页码：2109 / 2111
页数：3
相关论文
共 16 条
  • [1] Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility
    Albertí, S
    García-Rey, C
    Domínguez, MA
    Aguilar, L
    Cercenado, E
    Gobernado, M
    García-Perea, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) : 2385 - 2390
  • [2] Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus
    Banks, DJ
    Porcella, SF
    Barbian, KD
    Martin, JM
    Musser, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) : 1898 - 1908
  • [3] Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci
    Beall, B
    Facklam, RR
    Elliott, JA
    Franklin, AR
    Hoenes, T
    Jackson, D
    Laclaire, L
    Thompson, T
    Viswanathan, R
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (10) : 893 - 898
  • [4] Emergence of macrolide-resistant Streptococcus pyogenes strains in French children
    Bingen, E
    Bidet, P
    Mihaila-Amrouche, L
    Doit, C
    Forcet, S
    Brahimi, N
    Bouvet, A
    Cohen, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3559 - 3562
  • [5] Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis
    Bisno, AL
    Gerber, MA
    Gwaltney, JM
    Kaplan, EL
    Schwartz, RH
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) : 113 - 125
  • [6] Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy
    Dicuonzo, G
    Fiscarelli, E
    Gherardi, G
    Lorino, G
    Battistoni, F
    Landi, S
    De Cesaris, M
    Petitti, T
    Beall, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) : 3987 - 3990
  • [7] Streptococcus agalactiae in a large Portuguese teaching hospital:: Antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates
    Figueira-Coelho, J
    Ramirez, M
    Salgado, MJ
    Melo-Cristino, J
    [J]. MICROBIAL DRUG RESISTANCE, 2004, 10 (01) : 31 - 36
  • [8] Reemergence of macrolide resistance in pharyngeal isolates of group A streptococci in Southwestern Pennsylvania
    Green, M
    Martin, JM
    Barbadora, KA
    Beall, B
    Wald, ER
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 473 - 476
  • [9] Increased prevalence of erythromycin resistance in streptococci:: Substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan
    Hsueh, PR
    Teng, LJ
    Lee, LN
    Yang, PC
    Ho, SW
    Lue, HC
    Luh, KT
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (01) : 27 - 33
  • [10] Erythromycin resistance genes in group A streptococci in Finland
    Kataja, J
    Huovinen, P
    Skurnik, M
    Seppälä, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 48 - 52
12